212 related articles for article (PubMed ID: 28198097)
21. Antifungal activity of linalool in cases of Candida spp. isolated from individuals with oral candidiasis.
Dias IJ; Trajano ERIS; Castro RD; Ferreira GLS; Medeiros HCM; Gomes DQC
Braz J Biol; 2018 May; 78(2):368-374. PubMed ID: 28977047
[TBL] [Abstract][Full Text] [Related]
22. Antifungal activity of Boerhavia diffusa against some dermatophytic species of Microsporum.
Agrawal A; Srivastava S; Srivastava MM
Hindustan Antibiot Bull; 2003 Feb-2004 Nov; 45-46(1-4):1-4. PubMed ID: 16281821
[TBL] [Abstract][Full Text] [Related]
23. Susceptibility of Microsporum canis arthrospores to a mixture of chemically defined essential oils: a perspective for environmental decontamination.
Nardoni S; Tortorano A; Mugnaini L; Profili G; Pistelli L; Giovanelli S; Pisseri F; Papini R; Mancianti F
Z Naturforsch C J Biosci; 2015; 70(1-2):15-24. PubMed ID: 25854840
[TBL] [Abstract][Full Text] [Related]
24. In vitro activities of antifungal agents against clinical isolates of dermatophytes from animals.
Itoi S; Kano R; Hasegawa A; Kamata H
J Vet Med Sci; 2012 Aug; 74(8):1067-9. PubMed ID: 22467073
[TBL] [Abstract][Full Text] [Related]
25. Transcriptome sequencing revealed the inhibitory mechanism of ketoconazole on clinical
Wang M; Zhao Y; Cao L; Luo S; Ni B; Zhang Y; Chen Z
J Vet Sci; 2021 Jan; 22(1):e4. PubMed ID: 33522156
[TBL] [Abstract][Full Text] [Related]
26. Synergistic Effects of Efflux Pump Modulators on the Azole Antifungal Susceptibility of Microsporum canis.
Aneke CI; Rhimi W; Otranto D; Cafarchia C
Mycopathologia; 2020 Apr; 185(2):279-288. PubMed ID: 31894500
[TBL] [Abstract][Full Text] [Related]
27. Substituted 2-aminothiophenes: antifungal activities and effect on Microsporum gypseum protein profile.
Fogue PS; Lunga PK; Fondjo ES; De Dieu Tamokou J; Thaddée B; Tsemeugne J; Tchapi AT; Kuiate JR
Mycoses; 2012 Jul; 55(4):310-7. PubMed ID: 21831103
[TBL] [Abstract][Full Text] [Related]
28. In vitro evaluation of antifungal susceptibility and keratinase, elastase, lipase and DNase activities of different dermatophyte species isolated from clinical specimens in Iran.
Sharifzadeh A; Shokri H; Khosravi AR
Mycoses; 2016 Nov; 59(11):710-719. PubMed ID: 27291045
[TBL] [Abstract][Full Text] [Related]
29. Screening of selected medicinal plants for in vitro antidermatophytic activity.
Kalaivanan C; Chandrasekaran M; Venkatesalu V
J Mycol Med; 2013 Dec; 23(4):247-54. PubMed ID: 24135649
[TBL] [Abstract][Full Text] [Related]
30. In vitro evaluation of griseofulvin against clinical isolates of dermatophytes from Isfahan.
Chadeganipour M; Nilipour S; Havaei A
Mycoses; 2004 Dec; 47(11-12):503-7. PubMed ID: 15601457
[TBL] [Abstract][Full Text] [Related]
31. Antifungal activity, toxicity and chemical composition of the essential oil of Coriandrum sativum L. fruits.
Soares BV; Morais SM; dos Santos Fontenelle RO; Queiroz VA; Vila-Nova NS; Pereira CM; Brito ES; Neto MA; Brito EH; Cavalcante CS; Castelo-Branco DS; Rocha MF
Molecules; 2012 Jul; 17(7):8439-48. PubMed ID: 22785271
[TBL] [Abstract][Full Text] [Related]
32. The best type of inoculum for testing the antifungal drug susceptibility of Microsporum canis: In vivo and in vitro results.
Aneke CI; Rhimi W; Pellicoro C; Cantacessi C; Otranto D; Cafarchia C
Mycoses; 2020 Jul; 63(7):711-716. PubMed ID: 32299129
[TBL] [Abstract][Full Text] [Related]
33. In vitro activities of 15 antifungal drugs against a large collection of clinical isolates of Microsporum canis.
Abastabar M; Jedi A; Guillot J; Ilkit M; Eidi S; Hedayati MT; Shokohi T; Daie Ghazvini R; Rezaei-Matehkolaei A; Katiraee F; Javidnia J; Ahmadi B; Badali H
Mycoses; 2019 Nov; 62(11):1069-1078. PubMed ID: 31408550
[TBL] [Abstract][Full Text] [Related]
34. In vitro susceptibility of Microsporum canis and other dermatophyte isolates from veterinary infections during therapy with terbinafine or griseofulvin.
Hofbauer B; Leitner I; Ryder NS
Med Mycol; 2002 Apr; 40(2):179-83. PubMed ID: 12058731
[TBL] [Abstract][Full Text] [Related]
35. Potential effects of Trachyspermum copticum essential oil and propolis alcoholic extract on Mep3 gene expression of Microsporum canis isolates.
Khosravi AR; Shokri H; Sohrabi N
J Mycol Med; 2014 Sep; 24(3):e101-7. PubMed ID: 24746722
[TBL] [Abstract][Full Text] [Related]
36. In vitro susceptibility to antimycotics of Microsporum canis isolates from cats.
Puccini S; Valdré A; Papini R; Mancianti F
J Am Vet Med Assoc; 1992 Nov; 201(9):1375-7. PubMed ID: 1429182
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity of Citrus bergamia (bergamot) oil against clinical isolates of dermatophytes.
Sanguinetti M; Posteraro B; Romano L; Battaglia F; Lopizzo T; De Carolis E; Fadda G
J Antimicrob Chemother; 2007 Feb; 59(2):305-8. PubMed ID: 17118937
[TBL] [Abstract][Full Text] [Related]
38. Ethnoveterinary study for antidermatophytic activity of Piper betle, Alpinia galanga and Allium ascalonicum extracts in vitro.
Trakranrungsie N; Chatchawanchonteera A; Khunkitti W
Res Vet Sci; 2008 Feb; 84(1):80-4. PubMed ID: 17482221
[TBL] [Abstract][Full Text] [Related]
39. Antifungal activities of pelargonic and capric acid on Microsporum gypseum.
Chadeganipour M; Haims A
Mycoses; 2001 May; 44(3-4):109-12. PubMed ID: 11413921
[TBL] [Abstract][Full Text] [Related]
40. Adaptation of Microsporum gypseum to ketoconazole.
Lenhart K; Merkunová A
Acta Univ Palacki Olomuc Fac Med; 1989; 123():35-47. PubMed ID: 2533842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
